Status:
COMPLETED
COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-i Treatment Due to couGH in Slovakia
Lead Sponsor:
Bayer
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
In the light of ONTARGET and TRANSCEND studies results, it would be interesting to investigate the real-life telmisartan treatment tolerability. It is well known and accepted that the Real-life settin...
Eligibility Criteria
Inclusion
- Hypertension
- Age \> 18
- ACE-I related cough
Exclusion
- Current treatment with telmisartan
- Cholestatic disorders and severe hepatic failure
- Allergy to telmisartan
- Pregnancy and lactation period
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
980 Patients enrolled
Trial Details
Trial ID
NCT01217879
Start Date
January 1 2010
End Date
September 1 2010
Last Update
November 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Slovakia